Lantern Pharma, Inc. LTRN 深 沪
已收盘 04-02 16:00:00 美东时间
1.62
+0.200
+14.08%
华盛通- 最 高1.78
- 今 开1.37
- 成交量 130.18万股
- 最 低 1.36
- 昨 收 1.42
- 总市值 1823.26万
- 52周最高 5.7441
- 市盈率 静 --
- 换手率 11.57%
- 52周最低 1.11
- 委 比 52.67%
- 总股本 1125.47万
- 历史最高 24.84
- 量 比 0.24
- 振 幅 29.58%
- 历史最低 1.11
- 每 手 1
- 风险率 0.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% t...
03-31 20:05
Lantern Pharma Q4 EPS $(0.36) Beats $(0.46) Estimate
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.46) by 21.74 percent. This is a 33.33 percent increase over losses of $(0.54) per share from
03-31 04:22
Why Is Lantern Pharma Stock Soaring Monday?
Lantern Pharma shares rebound in premarket trading as the company debunks a false report regarding CEO Panna Sharma's departure.
03-30 21:33
Earnings Scheduled For March 30, 2026
Companies Reporting Before The Bell • Liberty All Star Equity (NYSE:USA) is est...
03-30 19:11
Lantern Pharma And Starlight Therapeutics Say FDA Clears IND Application For STAR-001 In Planned Phase 1 Pediatric Clinical Trial
The Planned Multicenter Phase 1 Trial Will Evaluate STAR-001 as Monotherapy and in Combination with Spironolactone in Children with Relapsed or Refractory CNS Malignancies, Including ATRT, DIPG, GBM, Medulloblastoma, and
03-27 19:31
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers CASI Pharmaceuticals (NASDAQ:CASI) shares rose 54.2% to $0.32 during W...
02-26 05:07
Lantern Pharma Announces Establishment Of A.I. Center Of Excellence And Advanced Agentic Labs In Bengaluru, India
The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and refinement of state-of-the-art ML-ready disease models and integration with global biopharma
01-12 22:09
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Mersana Therapeutics (NASDAQ:MRSN) stock increased by 208.1% to $27.33...
2025-11-13 20:06
Lantern Pharma Q3 EPS $(0.39) Beats $(0.54) Estimate
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.54) by 27.78 percent. This is a 7.14 percent increase over losses of $(0.42) per share from the
2025-11-13 19:03
